Skip to content

Clinical study on the Prevention of recurrence of choledocholithiasis after ERCP with Lidan Xiaoshi Mixture

Clinical study on the Prevention of recurrence of choledocholithiasis after ERCP with Lidan Xiaoshi Mixture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038011
Enrollment
Unknown
Registered
2020-09-08
Start date
2020-09-03
Completion date
Unknown
Last updated
2020-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choledocholithiasis

Interventions

Sponsors

Dongfang Hospital University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) All patients were preoperatively diagnosed with primary common bile duct calculi by first-line examination (laboratory examination + B-ultrasound) and (or) second-line examination (CT or MRCP imaging examination), and ERCP lithotomy was successfully completed; (2) Aged between 18 and 70 years; (3) No cholagogic drugs were taken within 1 month before surgery.

Exclusion criteria

Exclusion criteria: (1) Unsuccessful choledocholithiasis or lithotomy; (2) Patients with bile duct stricture; (3) Patients with cholecystolithiasis, intrahepatic cholangiolithiasis and other non-primary common bile duct stones; (4) Persons with mental illness; (5) Persons with other serious chronic diseases; (6) Pregnant and lactating women.

Design outcomes

Secondary

MeasureTime frame
Bile biochemistry;

Primary

MeasureTime frame
The recurrence rate;

Countries

China

Contacts

Public ContactZhang Liping

Beijing Univercity of Chinese Medicine

lpzhang2005@126.com+86 13911216028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026